Equities researchers at Craig Hallum started coverage on shares of Vital Farms (NASDAQ:VITL - Get Free Report) in a research report issued to clients and investors on Friday, Marketbeat Ratings reports. The firm set a "buy" rating and a $50.00 price target on the stock. Craig Hallum's price objective indicates a potential upside of 25.98% from the stock's previous close.
A number of other equities research analysts also recently weighed in on VITL. Jefferies Financial Group lowered their target price on shares of Vital Farms from $45.00 to $41.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. DA Davidson increased their price target on shares of Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. Finally, TD Cowen lowered their price objective on shares of Vital Farms from $46.00 to $41.00 and set a "buy" rating on the stock in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $41.00.
Get Our Latest Report on Vital Farms
Vital Farms Price Performance
NASDAQ:VITL traded up $0.95 during trading hours on Friday, hitting $39.69. The stock had a trading volume of 1,902,102 shares, compared to its average volume of 820,643. The firm has a market capitalization of $1.74 billion, a price-to-earnings ratio of 35.44 and a beta of 0.93. Vital Farms has a one year low of $14.16 and a one year high of $48.41. The company has a 50 day simple moving average of $34.84 and a two-hundred day simple moving average of $36.39. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.24 and a quick ratio of 2.81.
Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The business had revenue of $145.00 million during the quarter, compared to analysts' expectations of $145.27 million. During the same period in the previous year, the business earned $0.10 earnings per share. The firm's revenue was up 31.3% on a year-over-year basis. Research analysts forecast that Vital Farms will post 1.11 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, CEO Russell Diez-Canseco sold 44,728 shares of the firm's stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $37.66, for a total transaction of $1,684,456.48. Following the transaction, the chief executive officer now directly owns 613,797 shares in the company, valued at $23,115,595.02. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Matthew Ohayer sold 24,000 shares of the business's stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $39.09, for a total value of $938,160.00. Following the completion of the sale, the insider now owns 7,194,777 shares of the company's stock, valued at $281,243,832.93. The trade was a 0.33 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 113,381 shares of company stock valued at $4,411,862. 27.60% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Vital Farms
A number of hedge funds have recently modified their holdings of VITL. Brown Brothers Harriman & Co. bought a new stake in shares of Vital Farms in the third quarter worth about $35,000. Quarry LP increased its stake in shares of Vital Farms by 180.4% during the second quarter. Quarry LP now owns 1,290 shares of the company's stock valued at $60,000 after buying an additional 830 shares during the period. nVerses Capital LLC raised its holdings in shares of Vital Farms by 66.7% during the second quarter. nVerses Capital LLC now owns 2,000 shares of the company's stock valued at $94,000 after acquiring an additional 800 shares in the last quarter. Quest Partners LLC purchased a new stake in Vital Farms in the second quarter worth $97,000. Finally, Canada Pension Plan Investment Board bought a new stake in Vital Farms in the second quarter valued at $168,000. Hedge funds and other institutional investors own 98.59% of the company's stock.
About Vital Farms
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
